Amid Shortages, US Allows Expanded Production of ADHD Drug Vyvanse - Clinical Advisor

The DEA approved Takeda Pharmaceuticals to increase Vyvanse production by 24% to address ongoing ADHD drug shortages, with a 13,478-pound increase including 3434 pounds for domestic and 10,313 pounds for foreign demand.


Related News

Amid Shortages, US Allows Expanded Production of ADHD Drug Vyvanse - Clinical Advisor

The DEA approved Takeda Pharmaceuticals to increase Vyvanse production by 24% to address ongoing ADHD drug shortages, with a 13,478-pound increase including 3434 pounds for domestic and 10,313 pounds for foreign demand.

© Copyright 2024. All Rights Reserved by MedPath